Primary testicular lymphoma

Swiss Medical Weekly

Volumn 140, Issue SEPTEMBER, 2010, Pages

  Zouhair, Abderrahim ^a   Herrmann, Evelyn ^a   Ugurluer, Gamze ^a   Gaye, Papa Macoumba ^a   Mirimanoff, René Olivier ^a   Ozsahin, Mahmut ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Lymphoma; Radiotherapy; Testis; Treatment

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE; VINDESINE; ANTINEOPLASTIC AGENT;

ADVANCED CANCER; CANCER PROGNOSIS; CANCER STAGING; HUMAN; LYMPHOMA; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; ORCHIECTOMY; PARAAORTIC LYMPH NODE; PATHOLOGY; PRIMARY TESTICULAR LYMPHOMA; RARE DISEASE; REVIEW; SYSTEMATIC REVIEW; TESTIS CANCER; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CEREBROSPINAL FLUID; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SCROTAL RADIOTHERAPY;

EID: 84855985611     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2010.13076     Document Type: Review

References (35)

1. Gospodarowicz MK, Sutcliffe SB, Brown TC, et al. Patterns of disease in localized extranodal lymphomas. J Clin Oncol. 1987;5:875-80. (Pubitemid 17119992)
2. Zucca E, Roggero E, Bertoni F, et al. Primary extranodal non-Hodgkin's lymphomas. Part 1: gastrointestinal, cutaneous and genitourinary lymphomas: Ann Oncol. 1997;8:727-37. (Pubitemid 27397895)
3. Gundrum JD, Mathiason MA, Moore DB, et al. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival: comparison with primary nodal counterpart before and after the introduction of rituximab. J Clin Oncol. 2009;27:5227-32.
4. Vural F, Cagirgan S, Saydam G, et al. Primary Testicular Lymphoma. J Natl Med Assoc. 2007;99:1277-82. (Pubitemid 350246910)
5. Eskey CJ, Whitman GJ, Chew FS. Malignant lymphoma of the testis. Am J Roentgenol. 1997;169:822. (Pubitemid 27364998)
6. Vitolo U, Ferreri AJM, Zucca E. Primary testicular lymphoma. Crit Rev Oncol Hematol. 2008;65:183-9.
7. Ferry JA, Harris NL, Young RH, et al. Malignant lymphoma of the testis, epididymis and spermatic cord. A clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol. 1994;18:376-90. (Pubitemid 24093602)
8. Lambrechts AC, Looijenga LH, van't Veer MB, et al. Lymphomas with testicular localisation show a consistent BCL-2 expression without a translocation (14;18): a molecular and immunohistochemical study. Br J Cancer. 1995;71:73-7.
9. Moertel CL, Watterson J, McCormick SR, Simonton SC. Follicular large cell lymphoma of the testis in a child. Cancer. 1995;75:1182-6.
10. Lobo FD, Bansal R, Naik R, et al. Primary testicular lymphoma. J Indian Med Assoc. 1998;96:193-4. (Pubitemid 128519615)
11. Tondini C, Ferreri AJM, Siracusano L, et al. Diffuse large-cell lymphoma of the testis. J Clin Oncol. 1999;17:2854-8. (Pubitemid 29415244)
12. Salem YH, Miller HC. Lymphoma of genitourinary tract. J Urol. 1994;151:1162-70. (Pubitemid 24121908)
13. Moller MB, d'Amore F, Christensen BE. Testicular lymphoma: A population-based study of incidence, clinicopathological correlations and prognosis. The Danish Lymphoma Study Group, LYFO. Eur J Cancer. 1994;30:1760-4. (Pubitemid 24377147)
14. Spaepen K, Stroobants S, Dupont P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (18FFDG-PET) after first line chemotherapy in non-Hodgkin's lymphoma: is (18FFDG-PET) a valid alternative to conventional diagnostic methods. J Clin Oncol. 2001;19:414-9. (Pubitemid 32112853)
15. Touroutoglou N, Dimopoulos MA, Younes A, et al. Non-Hodgkin's lymphoma of the testis. Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy. J Clin Oncol. 1995;13:1361-7.
16. Fonseca R, Habermann TM, Colgan JP, et al. Testicular lymphoma is associated with a high incidence of extranodal recurrence. Cancer. 2000;88:154-61.
17. Crellin AM, Hudson BV, Bennett MH, et al. Non-Hodgkin's lymphoma of the testis. Radiother Oncol. 1993;27:99-106.
18. Lagrange JL, Ramaioli A, Theodore CH, et al. Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centers. Ann Oncol. 2001;12:1313-9. (Pubitemid 32994763)
19. Zouhair A, Weber D, Belkacemi Y, et al. Outcome and patterns of failure in testicular lymphoma: A multicenter rare cancer network study. Int J Radiat Oncol Biol Phys. 2002;52:652-6. (Pubitemid 34158726)
20. Zucca E, Conconi A, Mughal TI, et al. Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the international extranodal lymphoma study group. J Clin Oncol. 2003;21:20-7.
21. Miller TP, Dahlberg S, Cassady R, et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med. 1993;329:21-6.
22. Reyes F, Lepage E, Ganem G, et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med. 2005;352:1197-205. (Pubitemid 40397261)
23. Shahab N, Doll DC. Testicular lymphoma. Semin Oncol. 1999;26:259-69. (Pubitemid 29272894)
24. Miedler JD, MacLennan GT. Primary testicular lymphoma. J Urol. 2007;178:2645. (Pubitemid 350052248)
25. Connors JM, Klimo P, Voss N, et al. Testicular lymphoma: Improved outcome with early brief chemotherapy. J Clin Oncol. 1988;6:776-81.
26. Darby S, Hancock BW. Localised non-Hodgkin's lymphoma of the testis: the Sheffield lymphoma group experience. Int J Oncol. 2005;26:1093-9.
27. Linassier C, Desablens B, Lefrancq T, et al. Stage I-IIE primary non- Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS study group. Clin Lymphoma. 2002;3:167-72. (Pubitemid 36113688)
28. Tepperman BS, Gospodarowicz MK, Bush RS, et al. Non-Hodgkin's lymphoma of the testis. Radiology. 1982;142:203-8.
29. Park BB, Kim JG, Sohn SK, et al. Consideration of aggressive therapeutic strategies for primary testicular lymphoma. Am J Hematol. 2007;82:840-5.
30. Autorino R, Lamendola MG, De Sio M, et al. A complete response with rituximab in metastatic diffuse large B-cell lymphoma of the testis: case report. Int J Immunopathol Pharmacol. 2007;20:401-3. (Pubitemid 47104862)
31. McKelvey EM, Gottlieb JA, Wilson HE et al. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer. 1976;38:1484-93.
32. Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a standard regime (CHOP) with three intensive chemotherapy regimes for advanced non-Hodgkin's lymphoma. N Engl J Med. 1993;328:1002-6. (Pubitemid 23095683)
33. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-Bcell lymphoma. N Engl J Med. 2002;346:235-42. (Pubitemid 34438862)
34. Pfreundschuh M, Trumper L, Kloess M, et al. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL. Blood. 2004;104:634-41. (Pubitemid 38970554)
35. Pfreundschuh M, Schubert J, Ziepert M, et al. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in el-derly patients with aggressive CD 20+B-cell lymphomas: a randomised controlled trial (RICOVER-60). Lancet Oncol. 2008;9:105-16.